
Regentis Biomaterials Ord Shs
RGNT14.75MMarket Cap
0.00P/E TTM
After-hours 18:30 (ET)2.100USD0.000Regentis Biomaterials Ord Shs
RGNT Balance Sheet
You can check out the annual or quarterly balance sheets of Regentis Biomaterials Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing RGNT stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Regentis Biomaterials Ord Shs Have?
In its most recent quarterly, Regentis Biomaterials Ord Shs had 8.95M in cash and cash equivalents.
How Much Shareholders' Equity Does Regentis Biomaterials Ord Shs Have?
Regentis Biomaterials Ord Shs reported 4.74M in total shareholders' equity as of the latest reported quarter.